Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 1, 2008, Pages 44-55

  Barrera, Lourdes ^a   Mendoza, Felipe ^a   Zuñiga, Joaquín ^a   Estrada, Andrea ^a   Zamora, Ana C ^b   Melendro, Emma I ^c   Ramírez, Remedios ^d   Pardo, Annie ^d   Selman, Moisés ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Allergic alveolitis; Cytotoxic; Hypersensitivity pneumonitis; T cells; Th1 Th2 cells

Indexed keywords

BECLOMETASONE; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ALLERGIC PNEUMONITIS; ANTIGEN SPECIFICITY; ARTICLE; BIODIVERSITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DOSE REDUCTION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; MEMORY CELL; NATURAL KILLER CELL; NATURAL KILLER T CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADULT; AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; BRONCHOALVEOLAR LAVAGE FLUID; CD4-CD8 RATIO; CHEMOKINES; CHRONIC DISEASE; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG; LYMPHOCYTE COUNT; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MALE; MIDDLE AGED; PULMONARY FIBROSIS; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 37849029903     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200701-093OC     Document Type: Article

References (55)

1. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med 2004;25:531-547.
2. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pekkanen R, Muller N, Colby TV, Schuyler M, et al. HP Study Group. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003;168:952-958.
3. Perez-Padilla R, Salas J, Chapela R, Sanchez M, Carrillo G, Perez R, Sansores R, Gaxiola M, Selman M. Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis 1993;148:49-53.
4. Malinen A, Erkinjuntti-Pekkanen R, Partanen P, Rytkonen H, Vanninen R. Long-term sequelae of Farmer's lung disease in HRCT: a 14-year follow-up study of 88 patients and 83 matched control farmers. Eur Radiol 2003;13:2212-2221.
5. Semenzato G. Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection. Eur Respir J 1991;4:94-102.
6. Welker L, Jorres R, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004;24:1000-1006.
7. Suda T, Sato A, Ida M, Gemma H, Hayakawa H, Chida K. Hypersensitivity pneumonitis associated with home ultrasonic humidifiers. Chest 1995;107:711-717.
8. Dai H, Guzman J, Bauer P, Costabel U. Elevated levels of soluble TNF receptors in bronchoalveolar lavage fluid in extrinsic allergic alveolitis. Clin Exp Allergy 1999;29:1209-1213.
9. Ando M, Konishi K, Yoneda R, Tamura M. Difference in the phenotypes of bronchoalveolar lavage lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung: report of a nationwide epidemiologic study in Japan. J Allergy Clin Immunol 1991;87:1002-1009.
10. Yamasaki H, Ando M, Brazer W, Center D, Cruikshank W. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol 1999;163:3516-3523.
11. Sallusto F, Lanzavechia A. Central memory and effector memory T cell subsets: function, generation and maintenance. Annu Rev Immunol 2004;22:745-763.
12. Zaph C, Uzonna J, Beverley S, Scott P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med 2004;10:1104-1110.
13. + central and effector memory T cell subsets are largely distinct. Immunity 2003;18:193-204.
14. Wherry E, Teichgraber V, Becker T, Masopust D, Kaech S, Antia R, Von Adrian UH, Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003;4:225-234.
15. Barber D, Wherry EJ, Masopoust D, Baogong Z, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439:682-687.
16. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002;2:933-944.
17. Wynn T. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004;4:583-594.
18. Pardo A, Barrios R, Gaxiola M, Segura-Valdez L, Carrillo G, Estrada A, Mejia M, Selman M. Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med 2000;161:1698-1704.
19. Selman M, Pardo A, Barrera L, Estrada A, Watson S, Wilson K, Aziz N, Kaminski N, Zlotnik A. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188-198.
20. Disis ML, dela Rosa C, Goodell V, Kuan LY, Chang J, Kuus-Reichel K, Clay TM, Lyerly HK, Bhatia S, Ghanekar SA, et al. Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J Immunol Methods 2006;308:13-18.
21. Navarro C, Mendoza F, Barrera L, Segura-Valdez L, Gaxiola M, Paramo I, Selman M. Up-regulation of L-selectin and E-selectin in hypersensitivity pneumonitis. Chest 2002;121:354-360.
22. Chen R, Lowe L, Wilson J, Crowther E, Tzeggai K, Bishop J, Varro R. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin Chem 1999;9:1693-1697.
23. +T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78.
24. King M, Ismail A, Davis L, Karp D. Oxidative stress promotes polarization of human T cell differentiation toward a T helper 2 phenotype. J Immunol 2006;176:2765-2772.
25. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.
26. + cell dominant alveolitis and insidious onset. Chest 1993;104:38-43.
27. Girardi M. Immunosurveillance and immunoregulation by gammadelta T cells. J Invest Dermatol 2006;126:25-31.
28. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 2006;3:364-372.
29. + T cells to lung and subsequent pulmonary fibrosis. J Immunol 2006;177:4436-4443.
30. + cells adoptively transfer experimental hypersensitivity pneumonitis. Cell Immunol 1997;177:169-175.
31. Gudmundsson G, Hunninghake G. Interferon-γ is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 1997;99:2386-2390.
32. Pardo A, Selman M. Molecular mechanisms of pulmonary fibrosis. Front Biosci 2002;7:1743-1761.
33. Rennard S. Th2 cytokine regulation of type I collagen gel contraction mediated by human lung mesenchymal cells. Am J Physiol 2002;282:L1049-L1056.
34. Sempowski G, Derdak S, Phipps R. Interleukin-4 and interferon γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996;167:290-296.
35. Zhang D, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997;272:21597-21603.
36. Zheng D, Flavell R. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-596.
37. Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rβ2 chain or T-bet. Immunity 2003;18:415-428.
38. Kimura T, Ishii Y, Yoh K, Morishima Y, Iizuka T, Kiwamoto T, Matsuno Y, Homma S, Nomura A, Sakamoto T, et al. Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis. Am J Pathol 2006;169:96-104.
39. Vourlekis J, Schwarz M, Cherniack R, Curran-Everett D, Cool R, Tuder M, King T Jr, Brown K. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med 2004;116:662-668.
40. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005;23:877-900.
41. Matsuda H, Suda T, Sato J, Nagata T, Koide Y, Chida K, Nakamura H. α-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am J Respir Cell Mol Biol 2005;33:22-31.
42. Sharif S, Arreaza G, Zucker P, Mi Q, Sondhi J, Naidenko O, Kronenberg M, Koezuka Y, Delovitch T, Gombert J, et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 2001;7:1057-1062.
43. Kim J, Kim Y, Kim S, Chung J, Park W, Chung D. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-γ. Am J Pathol 2001;167:1231-1241.
44. Hwang S, Kim S, Park W, Chung D. IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-γ producing neutrophils. J Immunol 2006;177:5258-5268.
45. Kim CH, Butcher EC, Johnston B. Distinct subsets of human Vα24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol 2002;23:516-519.
46. Seino K, Taniguchi M. Functionally distinct NKT cell subsets and subtypes. J Exp Med 2005;202:1623-1626.
47. Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol 2005;6:873-879.
48. Zajac A. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998;188:2205-2213.
49. Gallimore A. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class-1 peptide complexes. J Exp Med 1998;187:1383-1393.
50. Pantaleo G, Koup RA. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 2004;10:806-810.
51. Letvin N, Walker B. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat Med 2003;9:861-866.
52. Rehermann B, Nascimbeni M. Immunology of hepatitis B and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229.
53. + T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls. J Neuroimmunol 2007;183:168-174.
54. + T-cells in adult T-cell leukemia/lymphoma. Int J Cancer 2007;121:2585-2590.
55. + T-cell immune responses during chronic viral infection. J Virol 2004;78:3578-3600.